Siemens Healthineers AG ADR SMMNY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $21.09
- Day Range
- $21.22–21.37
- 52-Week Range
- $19.20–28.92
- Bid/Ask
- $18.54 / $26.85
- Shares Outstanding
- 2.24B
- Market Cap
- $47.66B
- Volume/Avg
- 66,015 / 76,634
Key Statistics
- Price/Earnings (Normalized)
- 16.70
- Price/Sales
- 1.75
- Dividend Yield (Trailing)
- 2.79%
- Dividend Yield (Forward)
- 2.79%
- Dividend Payment Schedule
- Feb
- Total Yield
- 3.27%
Company Profile
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, and diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, and molecular imaging. The Varian business, now within Precision Therapies, (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Large Core
- Total Number of Employees
- 74,300
Competitors
Valuation
|
Metric
|
SMMNY
|
EKTA B
|
GEHC
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.70 | 14.69 | 13.82 |
Price/Book Value | 2.16 | 2.63 | 2.63 |
Price/Sales | 1.75 | 1.20 | 1.37 |
Price/Cash Flow | 12.67 | 9.19 | 12.34 |
Price/Earnings
SMMNY
EKTA B
GEHC
Financial Strength
|
Metric
|
SMMNY
|
EKTA B
|
GEHC
|
|---|---|---|---|
Quick Ratio | 0.74 | 0.62 | 0.84 |
Current Ratio | 1.16 | 0.86 | 1.26 |
Interest Coverage | 7.88 | 1.19 | 7.15 |
Quick Ratio
SMMNY
EKTA B
GEHC
Profitability
|
Metric
|
SMMNY
|
EKTA B
|
GEHC
|
|---|---|---|---|
Return on Assets (Normalized) | 5.00% | 1.83% | 5.78% |
Return on Equity (Normalized) | 12.25% | 6.33% | 20.45% |
Return on Invested Capital (Normalized) | 12.99% | 5.06% | 11.38% |
Return on Assets
SMMNY
EKTA B
GEHC
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|s%Y#$j! | LOCK|#CD$ | $169B | |||
| Medtronic PLC
MDT
| LOCK|&M&dxtr | LOCK|J#Xbr | $110B | |||
| Stryker Corp
SYK
| LOCK|HN@Fxl&L | LOCK|#Ts | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|vsd$Mkp | LOCK|?y&Y | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Cc>m^%Rf | LOCK|%GdS^ | $49B | |||
| DexCom Inc
DXCM
| LOCK|&#Lz>!Kv | LOCK|WQY< | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Qy&zZ%z | LOCK|Z< | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|q@d | LOCK|&< | $23B | |||
| Steris PLC
STE
| LOCK|R<C^Jyp | LOCK|K<W&S | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|x!f#&KgY | LOCK|%% | $17B |
United States